Stock listing

0PB Stock Price, News, Filings & Events — Puma Biotechnology Inc

Selected listing: 0PB · TRADEGATE · EUR · DE

This page tracks Puma Biotechnology Inc's 0PB:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0PB:TRADEGATE. 0PB:TRADEGATE is the stock-level entry point for investors researching Puma Biotechnology Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Puma Biotechnology Inc (PBYI) is a public company based in the United States, focusing on the development and commercialization of innovative cancer therapies. With a market capitalization of approximately $434.2 million, Puma aims to address unmet medical needs in oncology. The company is committed to advancing its pipeline of targeted treatments for patients with various types of cancer.

0PB:TRADEGATEEURDEUpdated July 21, 2026
Puma Biotechnology Inc logo
Ticker
0PB:TRADEGATE
Asset type
Stock
Market cap
$434.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TRADEGATE
Currency
EUR

Puma Biotechnology Inc 0PB:TRADEGATE stock context

This page tracks Puma Biotechnology Inc's 0PB:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0PB:TRADEGATE. 0PB:TRADEGATE is the stock-level entry point for investors researching Puma Biotechnology Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Puma Biotechnology Inc (PBYI) is a public company based in the United States, focusing on the development and commercialization of innovative cancer therapies. With a market capitalization of approximately $434.2 million, Puma aims to address unmet medical needs in oncology. The company is committed to advancing its pipeline of targeted treatments for patients with various types of cancer.

Research Puma Biotechnology Inc

Alternate listings